Home Halogens 1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-1,3-dimethyl-, compd. with2-amino-2-methyl-1-propanol (1:1)OTHER CA INDEX NAMES:1-Propanol, 2-amino-2-methyl-, compd. with8-bromo-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)

1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-1,3-dimethyl-, compd. with2-amino-2-methyl-1-propanol (1:1)OTHER CA INDEX NAMES:1-Propanol, 2-amino-2-methyl-, compd. with8-bromo-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)

CAS No.:
606-04-2
Catalog Number:
AG00IAQ1
Molecular Formula:
C11H18BrN5O3
Molecular Weight:
348.1963
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
100mg
98%(HPLC)
In Stock USA
United States
$57
- +
1g
98%(HPLC)
In Stock USA
United States
$118
- +
5g
98%(HPLC)
In Stock USA
United States
$308
- +
Product Description
Catalog Number:
AG00IAQ1
Chemical Name:
1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-1,3-dimethyl-, compd. with2-amino-2-methyl-1-propanol (1:1)OTHER CA INDEX NAMES:1-Propanol, 2-amino-2-methyl-, compd. with8-bromo-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
CAS Number:
606-04-2
Molecular Formula:
C11H18BrN5O3
Molecular Weight:
348.1963
MDL Number:
MFCD00867328
IUPAC Name:
2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7H-purine-2,6-dione
InChI:
InChI=1S/C7H7BrN4O2.C4H11NO/c1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14;1-4(2,5)3-6/h1-2H3,(H,9,10);6H,3,5H2,1-2H3
InChI Key:
ATOTUUBRFJHZQG-UHFFFAOYSA-N
SMILES:
Brc1nc2c([nH]1)n(C)c(=O)n(c2=O)C.OCC(N)(C)C
EC Number:
210-103-4
UNII:
UA8U0KJM72
Properties
Complexity:
340  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
347.059g/mol
Formal Charge:
0
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
348.201g/mol
Monoisotopic Mass:
347.059g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
116A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment. European journal of obstetrics, gynecology, and reproductive biology 20100901
Fixed drug eruption caused by pamabrom. Clinical and experimental dermatology 20091001
Serum sickness-like reaction to Pamabrom. Journal of drugs in dermatology : JDD 20060301
Is acetaminophen, and its combination with pamabrom, an effective therapeutic option in primary dysmenorrhoea? Expert opinion on pharmacotherapy 20040301
Properties